BIT Capital GmbH Purchases 1,522 Shares of Axon Enterprise, Inc $AXON

BIT Capital GmbH grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 75.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,535 shares of the biotechnology company’s stock after purchasing an additional 1,522 shares during the quarter. BIT Capital GmbH’s holdings in Axon Enterprise were worth $2,537,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of AXON. Stone House Investment Management LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at $29,000. Whipplewood Advisors LLC boosted its stake in Axon Enterprise by 192.9% in the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after acquiring an additional 27 shares during the last quarter. Root Financial Partners LLC bought a new position in Axon Enterprise in the third quarter valued at approximately $34,000. Darwin Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 2nd quarter valued at $37,000. Finally, NewSquare Capital LLC boosted its position in shares of Axon Enterprise by 96.2% in the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after purchasing an additional 25 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

Shares of AXON opened at $441.12 on Friday. The company has a quick ratio of 2.89, a current ratio of 3.12 and a debt-to-equity ratio of 0.57. Axon Enterprise, Inc has a twelve month low of $396.41 and a twelve month high of $885.91. The stock has a market capitalization of $34.81 billion, a P/E ratio of 139.60, a P/E/G ratio of 12.96 and a beta of 1.48. The company has a 50 day moving average of $547.24 and a 200-day moving average of $640.09.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on AXON shares. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, November 5th. Barclays decreased their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a report on Thursday, November 6th. Northcoast Research raised shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target for the company in a report on Tuesday, January 6th. Wall Street Zen downgraded Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Finally, UBS Group reduced their target price on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $805.71.

Insiders Place Their Bets

In other news, CAO Jennifer H. Mak sold 1,134 shares of the stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $600.00, for a total value of $680,400.00. Following the completion of the sale, the chief accounting officer owned 13,740 shares of the company’s stock, valued at approximately $8,244,000. This represents a 7.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the transaction, the president owned 249,502 shares in the company, valued at approximately $137,874,805.20. The trade was a 7.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 48,040 shares of company stock valued at $27,249,338 in the last quarter. 4.40% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.